Innovent Reports Preclinical IAR177 Data in Rheumatoid Arthritis Models
Innovent says preclinical data show IAR177 outperformed single-target blockade in rheumatoid arthritis models.
Innovent says preclinical data show IAR177 outperformed single-target blockade in rheumatoid arthritis models.